January 23, 2020
UC San Diego School of Medicine researchers identified several genetic switches, or transcription factors, that determine whether or not liver cells produce collagen — providing a new therapeutic target for liver fibrosis.
August 11, 2022
In mouse studies, UC San Diego researchers find that excess alcohol consumption alters gut microbiome but latter is not directly or significantly linked to liver disease.
August 13, 2015
The mechanisms that allow the liver to repair and regenerate itself have long been a matter of debate. Now researchers at University of California, San Diego School of Medicine have discovered a population of liver cells that are better at regenerating liver tissue than ordinary liver cells, or hepatocytes. The…
August 18, 2022
New medication now available at UC San Diego Health allows for less frequent visits for patients, helping improve quality of life.
July 19, 2012
An international team of scientists, led by researchers from the department of pediatrics at the UC San Diego School of Medicine, have identified the first reported inhibitors of a key enzyme involved in survival of the parasite responsible for malaria. Their findings, which may provide the basis for anti-malarial drug…
February 6, 2020
After identifying a molecular pathway that allows nonalcoholic steatohepatitis (NASH) to progress into liver cell death, University of California San Diego School of Medicine researchers were able to use these pathways to halt further liver damage.
September 27, 2016
Five engineering graduate students from the University of California, San Diego have been named 2017 Siebel Scholars. The Siebel Scholars program recognizes exceptional students at the world’s leading graduate schools of business, computer science, and bioengineering and provides them with a financial award for their final year of studies.
August 23, 2023
A grant of nearly $3.5 million from The Leona M. and Harry B. Helmsley Charitable Trust is supporting research at UC San Diego to identify better, more targeted treatments for people living with Crohn’s disease.
March 29, 2019
In a study of people with nonalcoholic fatty liver disease and their twins and other close relatives, UC San Diego researchers were able to diagnose liver cirrhosis simply by analyzing a person’s stool microbes.
May 12, 2016
A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by…
